Akhil Santhosh, Medical Oncology Specialist at MVR Cancer Centre and Research Institute, shared a post on X:
“FRUTIGA phase 3 RCT: Fruquitinib with or without paclitaxel in pretreated advanced ca stomach.
Median PFS 5.6m vs 2.7m in favour of the combination.
Median OS 9.6m vs 8.4, not statistically significant.”